Medicus Pharma Ltd.
Medicus Pharma Ltd.
Subscribe to unlock 17+ years of financial data
Subscribe to unlock 17+ years of data
Financial Statements
Values in Millions ($) | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | Subscriber-only column | Subscriber-only column | Subscriber-only column | Subscriber-only column | Financial statements beyond 3 years are for subscribers only. Unlock 17+ years of income statements, balance sheets, and cash flow statements Start 7-day free trial |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
Assets | ||||||||||||
Assets Current | ||||||||||||
Cash And Cash Equivalents At Carrying Value | 15 | 6 | 9 | 9 | 10 | 4 | 4 | |||||
Prepaid Expense Current | 2 | 1 | 1 | 1 | 1 | 1 | 1 | |||||
Deferred Costs Current | 0 | 0 | 0 | - | - | - | 0 | |||||
Assets Current | 17 | 7 | 10 | 10 | 11 | 5 | 5 | |||||
Operating Lease Right Of Use Asset | 0 | 0 | 0 | 0 | 0 | 0 | 0 | |||||
Deferred Costs | - | - | - | - | 1 | 0 | - | |||||
Assets | 27 | 7 | 10 | 10 | 12 | 6 | 6 | |||||
Liabilities And Stockhold… | ||||||||||||
Liabilities Current | ||||||||||||
Accounts Payable Current | 7 | 2 | 3 | 2 | 2 | 2 | 1 | |||||
Accrued Liabilities And Other Liabilities | 0 | 1 | 1 | 2 | 2 | 1 | 1 | |||||
Operating Lease Liability Current | 0 | 0 | 0 | 0 | 0 | 0 | 0 | |||||
Debt Current | - | 2 | 5 | 7 | 5 | - | 0 | |||||
Liabilities Current | 11 | 6 | 10 | 11 | 9 | 3 | 2 | |||||
Long Term Loans Payable | 0 | 0 | 0 | 0 | - | - | 0 | |||||
Operating Lease Liability Noncurrent | 0 | 0 | 0 | 0 | 0 | 0 | 0 | |||||
Liabilities | 29 | 6 | 10 | 11 | 9 | 4 | 3 | |||||
Stockholders Equity | ||||||||||||
Common Stock Value | 74 | 67 | 57 | 0 | 38 | 33 | 31 | |||||
Additional Paid In Capital | 9 | 7 | 7 | 6 | 6 | 3 | 2 | |||||
Accumulated Other Comprehensive Income Loss Net Of… | 0 | -0 | 0 | 0 | - | - | 0 | |||||
Retained Earnings Accumulated Deficit | -85 | -73 | -64 | -0 | -40 | -34 | -29 | |||||
Stockholders Equity | -2 | 1 | -0 | -1 | 3 | 2 | 3 | |||||
Minority Interest | 0 | 0 | 0 | 0 | - | - | 0 | |||||
Liabilities And Stockholders Equity | 27 | 7 | 10 | 10 | 12 | 6 | 6 | |||||
Common Stock No Par Value | 0 | 0 | 0 | 0 | 0 | 0 | 0 | |||||
Common Stock Shares Authorized | 60 | 40 | 25 | - | - | - | 12 | |||||
Common Stock Shares Issued | 60 | 40 | 25 | 21 | 16 | 13 | 12 | |||||
Shares Outstanding | 60 | 40 | 25 | 21 | 16 | 13 | 12 | |||||
Subscribe to unlock 17+ years of financial data, unlimited metrics, and saved tables
Subscribe to unlock 17+ years of data, unlimited metrics, and saved tables
Custom Table
Subscribe to unlock 17+ years of financial data, unlimited metrics, transformations, and saved visuals
Subscribe to unlock 17+ years of data, unlimited metrics, transformations, and saved visuals
Interactive Financial Visualizations
Subscribe to unlock 17+ years of financial data
Subscribe to unlock 17+ years of data
Earnings Market Reaction
| Fiscal Year | Q1 1 Month | Q1 2 Month | Q1 3 Month | Q2 1 Month | Q2 2 Month | Q2 3 Month | Q3 1 Month | Q3 2 Month | Q3 3 Month | Q4 1 Month | Q4 2 Month | Q4 3 Month |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026 | 3.86% | 23.44% | -18.40% | - | - | - | - | - | - | - | - | - |
| 2025 | -43.21% | -30.45% | -47.12% | -4.57% | 28.93% | 23.86% | -6.82% | -27.27% | -45.91% | -28.95% | -39.07% | -31.58% |
| 2024 | - | - | - | - | - | - | - | - | - | 27.80% | 115.02% | -16.93% |
Earnings Market Reaction data beyond 3 years is for subscribers only. Unlock the full earnings market reaction history Start 7-day free trial | ||||||||||||
Subscribe to unlock 17+ years of financial data and 90+ calculated metrics
Subscribe to unlock 17+ years of data and 90+ calculated metrics
Performance and Valuation Metrics
Rows marked with a lock icon are subscribers only — subscribe to unlock 90+ calculated metrics and 17+ years of history.
Subscribe to unlock 17+ years of financial data
Subscribe to unlock 17+ years of data
Insider Transactions
Subscribe to unlock 17+ years of financial data
Subscribe to unlock 17+ years of data
Institutional Ownership
Medicus Pharma Ltd. (MDCX) — SEC Financial Statements & Analysis
Medicus Pharma Ltd. (MDCX) is a pharmaceutical preparations company, incorporated in A6. Medicus Pharma Ltd. trades on Nasdaq as: MDCX, MDCXW. Based on its latest SEC filing (Form 10-Q, period ending 2026-06-30), Medicus Pharma Ltd. reported a Debt-to-Equity ratio of -16.72x, a Price-to-Book (P/B) ratio of -14.23x (TTM), at a market cap of $24.55M. Figures below are sourced from SEC EDGAR, as-filed.
- Debt To Equity
- -16.72x
- P/B TTM
- -14.23x
- Market Cap
- $24.55M
Data as of 2026-06-30 · Source: SEC EDGAR
Frequently Asked Questions
What industry is Medicus Pharma Ltd. in?
Medicus Pharma Ltd. (MDCX) operates in the Pharmaceutical Preparations industry.
What is MDCX's market cap?
Medicus Pharma Ltd. (MDCX) has a market capitalization of $24.55M as of 2026-06-30.
What exchange does MDCX trade on?
Medicus Pharma Ltd. (MDCX) trades on the Nasdaq.
Where is Medicus Pharma Ltd. incorporated?
Medicus Pharma Ltd. is incorporated in Ontario, Canada.